A Study to Evaluate the Safety and Efficacy of Aprepitant (MK0869) for Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients
NCT01757210
·
clinicaltrials.gov ↗
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Chemotherapy-Induced Nausea and Vomiting
Sponsor
West Virginia University Healthcare